MAPT and Alzheimer disease: Compared with the neuropsychological tests, braining imaging, and amyloid-beta and tau in cerebrospinal fluid that are widely used in clinical AD examination [2, 25], reach-to-grasp are noninvasive, relative low cost and easy to perform, thereby would be suitable for routine detection of AD in a large population.